CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
